The process of researching, developing, and ultimately commercializing a treatment for patients, regardless of the therapy area, is a long and costly one with slim chances for success. For example, the average R&D investment in developing a new drug treatment is $1.3 billion, the median development time is 5.9 to 7.2 years for non-oncology and 13.1 years for […]
Advertisement